Osteoconductivity and growth factor production by MG63 osteoblastic cells on bioglass-coated orthopedic implants

Biotechnology and Bioengineering

Volumn 108, Issue 2, 2011, Pages 454-464

  Tan, Fei ^a   Naciri, Mariam ^a   Al Rubeai, Mohamed ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Bioactive glass; Growth factors; Hydroxyapatite coating; MRNA; Osteoconduction

Indexed keywords

ANGIOGENESIS; ANGIOPOIETINS; ASEPTIC LOOSENING; BASIC FIBROBLAST GROWTH FACTOR; BIO-GLASS; BIOPROCESSES; CELL ATTACHMENTS; DIFFERENTIATION MARKERS; GROWTH FACTOR; HYDROXYAPATITE COATING; INDUCIBLE NITRIC OXIDE SYNTHASE; MRNA; MRNA LEVEL; NOVEL COATINGS; ORTHOPEDIC IMPLANT; OSTEOBLASTIC CELLS; OSTEOCONDUCTION; OSTEOCONDUCTIVITY; OSTEOGENIC DIFFERENTIATION; PROTEIN ADSORPTION; QUANTITATIVE AND QUALITATIVE ASSESSMENTS; THERAPEUTIC FUNCTIONS; TOTAL HIP REPLACEMENTS;

ADHESION; ADSORPTION; APATITE; CELL ADHESION; CELL CULTURE; CELL PROLIFERATION; COMPOSITE COATINGS; HIP PROSTHESES; HYDROXYAPATITE; NITRIC OXIDE; PEPTIDES;

BIOACTIVE GLASS;

ANGIOPOIETIN; BASIC FIBROBLAST GROWTH FACTOR; BIOCHEMICAL MARKER; CALCIUM ION; GLASS; GROWTH FACTOR; HYDROXYAPATITE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; SILICON;

ADSORPTION; ANGIOGENESIS; ARTICLE; BONE CONDUCTION; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GONIOMETRY; HUMAN; HUMAN CELL; HYDROPHILICITY; IMPLANT; MATERIAL COATING; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PROSTHESIS LOOSENING; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TOTAL HIP PROSTHESIS;

ANGIOPOIETINS; BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CERAMICS; COATED MATERIALS, BIOCOMPATIBLE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NITRIC OXIDE SYNTHASE; OSTEOBLASTS; PROSTHESES AND IMPLANTS;

EID: 78650215550     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.22955     Document Type: Article

References (45)

1. Abu-Amer Y, Darwech I, Clohisy J. 2007. Aseptic loosening of total joint replacements: Mechanisms underlying osteolysis and potential therapies. Arthritis Res Ther 9 (Suppl 1): S6.
2. Albrektsson T, Johansson C. 2001. Osteoinduction, osteoconduction and osseointegration. Eur Spine J 10(2): S96-S101.
3. Anselme K. 2000. Osteoblast adhesion on biomaterials. Biomaterials 21(7): 667-681.
4. Best SM, Porter AE, Thian ES, Huang J. 2008. Bioceramics: Past, present and for the future. J Eur Ceramic Soc 28(7): 1319-1327.
5. Bilezikian J, Raisz L, Martin J. 2008. Principles of bone biology. London, UK: Academic Press.
6. Bodo M, Lilli C, Bellucci C, Carinci P, Calvitti M, Pezzetti F, Stabellini G, Bellocchio S, Balducci C, Carinci F, Baroni T. 2002. Basic fibroblast growth factor autocrine loop controls human osteosarcoma phenotyping and differentiation. Mol Med 8(7): 393-404.
7. Choi C-R, Yu H-S, Kim C-H, Lee J-H, Oh C-H, Kim H-W, Lee H-H. 2010. Bone cell responses of titanium blasted with bioactive glass particles. J Biomater Appl 25(2): 99-117.
8. Cholewa-Kowalska K, Kokoszka J, Laczka M, Niedzwiedzki L, Madej W, Osyczka AM. 2009. Gel-derived bioglass as a compound of hydroxyapatite composites. Biomed Mater 4(5): 055007.
9. Cooper LF, Masuda T, Yliheikkila PK, Felton DA. 1998. Generalizations regarding the process and phenomenon of osseointegration. Part II. In vitro studies. Int J Oral Maxillofac Implants 13(2): 163-174.
10. Foppiano S, Marshall SJ, Marshall GW, Saiz E, Tomsia AP. 2007. Bioactive glass coatings affect the behavior of osteoblast-like cells. Acta Biomater 3(5): 765-771.
11. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126(1): 131-138.
12. Hench LL. 1991. Bioceramics: From concept to clinic. J Am Ceramic Soc 74(7): 1487-1510.
13. Hench LL. 1998. Bioceramics. J Am Ceramic Soc 81(7): 1705-1728.
14. Hench L. 2006. The story of Bioglass®. J Mater Sci Mater Med 17(11): 967-978.
15. Holash J, Wiegand SJ, Yancopoulos GD. 1999. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18(38): 5356-5362.
16. Horner A, Bord S, Kelsall AW, Coleman N, Compston JE. 2001. Tie2 ligands angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial cell growth factor in growing human bone. Bone 28(1): 65-71.
17. Hu YC, Zhong JP. 2009. Osteostimulation of bioglass. Chinese Med J 122: 2386-2389.
18. Kasama T, Isozaki T, Odai T, Matsunawa M, Wakabayashi K, Takeuchi HT, Matsukura S, Adachi M, Tezuka M, Kobayashi K. 2007. Expression of angiopoietin-1 in osteoblasts and its inhibition by tumor necrosis factor-alpha and interferon-gamma. Transl Res 149(5): 265-273.
19. Kieswetter K, Schwartz Z, Hummert TW, Cochran DL, Simpson J, Dean DD, Boyan BD. 1996. Surface roughness modulates the local production of growth factors and cytokines by osteoblast-like MG-63 cells. J Biomed Mater Res 32(1): 55-63.
20. Kokubo T. 2008. Bioceramics and their clinical applications. Abington, Cambridge, England: Woodhead Publishing Limited.
21. Koller G, Cook R, Thompson I, Watson T, Di Silvio L. 2007. Surface modification of titanium implants using bioactive glasses with air abrasion technologies. J Mater Sci Mater Med 18(12): 2291-2296.
22. Landor I, Vavrik P, Sosna A, Jahoda D, Hahn H, Daniel M. 2007. Hydroxyapatite porous coating and the osteointegration of the total hip replacement. Arch Orthop Trauma Surg 127(2): 81-89.
23. Lee TM, Chang E, Wang BC, Yang CY. 1996. Characteristics of plasma-sprayed bioactive glass coatings on Ti-6A1-4V alloy: An in vitro study. Surf Coatings Technol 79(1-3): 170-177.
24. Lewinson D, Maor G, Rozen N, Rabinovich I, Stahl S, Rachmiel A. 2001. Expression of vascular antigens by bone cells during bone regeneration in a membranous bone distraction system. Histochem Cell Biol 116(5): 381-388.
25. Liekens S, De Clercq E, Neyts J. 2001. Angiogenesis: Regulators and clinical applications. Biochem Pharmacol 61(3): 253-270.
26. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta]CT method. Methods 25(4): 402-408.
27. Morris DC, Masuhara K, Takaoka K, Ono K, Anderson HC. 1992. Immunolocalization of alkaline phosphatase in osteoblasts and matrix vesicles of human fetal bone. Bone Miner 19(3): 287-298.
28. Narayan R. 2009. Biomedical materials. New York, USA: Springer Science+Business Media.
29. O'donoghue J, Haverty D. EnBIO Ltd (Bishopstown, IE), assignee. 2008 WO2008/033867, 2008. Method of Doping Surfaces.
30. O'Hare P, Meenan BJ, Burke GA, Byrne G, Dowling D, Hunt JA. 2010. Biological responses to hydroxyapatite surfaces deposited via a co-incident microblasting technique. Biomaterials 31(3): 515-522.
31. O'Neill L, O'Sullivan C, O'Hare P, Sexton L, Keady F, O'Donoghue J. 2009. Deposition of substituted apatites onto titanium surfaces using a novel blasting process. Surf Coatings Technol 204(4): 484-488.
32. Paital SR, Dahotre NB. 2009. Calcium phosphate coatings for bio-implant applications: Materials, performance factors, and methodologies. Mater Sci Eng R Rep 66(1-3): 1-70.
33. Park J. 2008. Bioceramics: Properties, characterization, and applications. New York, USA: Springer Science+Business Media. 364.
34. Park B-H, Jang KY, Kim KH, Song KH, Lee SY, Yoon SJ, Kwon KS, Yoo W-H, Koh YJ, Yoon KH, et al. 2009. COMP-angiopoietin-1 ameliorates surgery-induced ischemic necrosis of the femoral head in rats. Bone 44(5): 886-892.
35. Park B-H, Yoon SJ, Jang KY, Kim M-R, Lee H-S, Kim K-B, Park H, Lee SY, Park HS, Lim ST, and others. 2010. COMP-angiopoietin-1 accelerates bone formation during distraction osteogenesis. Bone 46(5): 1442-1448.
36. Puskas BL, Menke NE, Huie P, Song Y, Ecklund K, Trindade MCD, Smith RL, Goodman SB. 2003. Expression of nitric oxide, peroxynitrite, and apoptosis in loose total hip replacements. J Biomed Mater Res A 66A(3): 541-549.
37. Rajaraman R, Rounds DE, Yen SPS, Rembaum A. 1974. A scanning electron microscope study of cell adhesion and spreading in vitro. Exp Cell Res 88(2): 327-339.
38. Santavirta S, Čeponis A, Solovieva SA, Hurri H, Jin J, Takagi M, Suda A, Konttinen YT. 1996. Periprosthetic microvasculature in loosening of total hip replacement. Arch Orthop Trauma Surg 115(5): 286-289.
39. Sargeant A, Goswami T. 2006. Hip implants: Paper V. Physiological effects. Mater Des 27(4): 287-307.
40. Sun J-Y, Yang Y-S, Zhong J, Greenspan DC. 2007. The effect of the ionic products of Bioglass® dissolution on human osteoblasts growth cycle in vitro. J Tissue Eng Regen Med 1(4): 281-286.
41. Tierney CM, Haugh MG, Liedl J, Mulcahy F, Hayes B, O'Brien FJ. 2009. The effects of collagen concentration and crosslink density on the biological, structural and mechanical properties of collagen-GAG scaffolds for bone tissue engineering. J Mech Behav Biomed Mater 2(2): 202-209.
42. Wang Y, Zhang S, Zeng X, Ma LL, Khor KA, Qian M. 2008. Initial attachment of osteoblastic cells onto sol-gel derived fluoridated hydroxyapatite coatings. J Biomed Mater Res A 84A(3): 769-776.
43. Xynos ID, Edgar AJ, Buttery LDK, Hench LL, Polak JM. 2000. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 276(2): 461-465.
44. Yafan Z, Chuanzhong C, Diangang W. 2005. The current techniques for preparing bioglass coatings. Surf Rev Lett 12(4): 505-513.
45. Zinger O, Zhao G, Schwartz Z, Simpson J, Wieland M, Landolt D, Boyan B. 2005. Differential regulation of osteoblasts by substrate microstructural features. Biomaterials 26(14): 1837-1847.